1. Home
  2. HLMN vs NTLA Comparison

HLMN vs NTLA Comparison

Compare HLMN & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HLMN
  • NTLA
  • Stock Information
  • Founded
  • HLMN 1964
  • NTLA 2014
  • Country
  • HLMN United States
  • NTLA United States
  • Employees
  • HLMN N/A
  • NTLA N/A
  • Industry
  • HLMN Industrial Machinery/Components
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • HLMN Consumer Discretionary
  • NTLA Health Care
  • Exchange
  • HLMN Nasdaq
  • NTLA Nasdaq
  • Market Cap
  • HLMN 2.2B
  • NTLA 1.4B
  • IPO Year
  • HLMN N/A
  • NTLA 2016
  • Fundamental
  • Price
  • HLMN $9.38
  • NTLA $12.22
  • Analyst Decision
  • HLMN Buy
  • NTLA Buy
  • Analyst Count
  • HLMN 6
  • NTLA 17
  • Target Price
  • HLMN $14.20
  • NTLA $56.63
  • AVG Volume (30 Days)
  • HLMN 990.7K
  • NTLA 2.3M
  • Earning Date
  • HLMN 02-20-2025
  • NTLA 02-20-2025
  • Dividend Yield
  • HLMN N/A
  • NTLA N/A
  • EPS Growth
  • HLMN N/A
  • NTLA N/A
  • EPS
  • HLMN 0.04
  • NTLA N/A
  • Revenue
  • HLMN $1,470,841,000.00
  • NTLA $43,086,000.00
  • Revenue This Year
  • HLMN $1.80
  • NTLA $52.50
  • Revenue Next Year
  • HLMN $4.72
  • NTLA $0.42
  • P/E Ratio
  • HLMN $250.44
  • NTLA N/A
  • Revenue Growth
  • HLMN N/A
  • NTLA N/A
  • 52 Week Low
  • HLMN $8.43
  • NTLA $11.34
  • 52 Week High
  • HLMN $12.08
  • NTLA $34.87
  • Technical
  • Relative Strength Index (RSI)
  • HLMN 24.95
  • NTLA 40.01
  • Support Level
  • HLMN $9.56
  • NTLA $11.34
  • Resistance Level
  • HLMN $10.02
  • NTLA $12.30
  • Average True Range (ATR)
  • HLMN 0.32
  • NTLA 0.67
  • MACD
  • HLMN -0.11
  • NTLA 0.01
  • Stochastic Oscillator
  • HLMN 2.30
  • NTLA 32.47

About HLMN Hillman Solutions Corp.

Hillman Solutions Corp is a provider of hardware-related products and related merchandising services to retail markets in North America. The company sells its products to hardware stores, home centers, mass merchants, pet supply stores, and other retail outlets. Its product lines include thousands of small parts such as fasteners and related hardware items; threaded rod and metal shapes; keys and accessories; builder's hardware; personal protective equipment, such as gloves and eye-wear; and identification items, such as tags and letters, numbers, and signs. The segments of the group are Hardware and Protective Solutions, which is the key revenue-generating segment; Robotics and Digital Solutions; and Canada. It has a business presence in the US, Canada and Mexico.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: